132 related articles for article (PubMed ID: 22024784)
1. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
Kaya G; Koçak E; Akbal E; Taş A; Köklü S
South Med J; 2011 Nov; 104(11):747-51. PubMed ID: 22024784
[TBL] [Abstract][Full Text] [Related]
2. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
3. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in Iranian patients with inflammatory bowel disease.
Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
[TBL] [Abstract][Full Text] [Related]
6. Bone density and bone metabolism in patients with inflammatory bowel disease.
Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M
Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and inflammatory bowel disease severity.
Lima CA; Lyra AC; Mendes CMC; Lopes MB; Coqueiro FG; Rocha R; Santana GO
Braz J Med Biol Res; 2017 Oct; 50(12):e6374. PubMed ID: 29069227
[TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for low bone mineral density in ulcerative colitis.
Bundela RPS; Ashdhir P; Narayan KS; Jain M; Pokharna RK; Nijhawan S
Indian J Gastroenterol; 2017 May; 36(3):193-196. PubMed ID: 28643272
[TBL] [Abstract][Full Text] [Related]
11. Updated bone mineral density status in Saudi patients with inflammatory bowel disease.
Ewid M; Al Mutiri N; Al Omar K; Shamsan AN; Rathore AA; Saquib N; Salaas A; Al Sarraj O; Nasri Y; Attal A; Tawfiq A; Sherif H
World J Gastroenterol; 2020 Sep; 26(35):5343-5353. PubMed ID: 32994692
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
Krela-Kaźmierczak I; Michalak M; Szymczak-Tomczak A; Łykowska-Szuber L; Stawczyk-Eder K; Waszak K; Kucharski MA; Dobrowolska A; Eder P
Pol Arch Intern Med; 2018 Aug; 128(7-8):447-454. PubMed ID: 30057387
[TBL] [Abstract][Full Text] [Related]
13. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
Boubaker J; Feki M; Hsairi M; Fekih M; Kaabachi N; Filali A; Mebazaa A
Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
[TBL] [Abstract][Full Text] [Related]
14. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
Ezzat Y; Hamdy K
Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
[TBL] [Abstract][Full Text] [Related]
15. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
16. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
17. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
19. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
20. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
